Indivior (LON:INDV) Stock Price Down 22.9% – Here’s Why

Indivior PLC (LON:INDV) traded down 22.9% during trading on Thursday . The stock traded as low as GBX 548.71 ($6.93) and last traded at GBX 669.50 ($8.46). 1,917,540 shares changed hands during trading, an increase of 170% from the average session volume of 710,287 shares. The stock had previously closed at GBX 868 ($10.97).

Wall Street Analysts Forecast Growth

Separately, Jefferies Financial Group reiterated a “buy” rating and set a GBX 1,800 ($22.74) price target on shares of Indivior in a report on Tuesday, December 17th.

Indivior Stock Down 5.9 %

The firm has a market cap of £1.08 billion, a PE ratio of -570.87, a P/E/G ratio of -5.57 and a beta of 0.19. The company has a debt-to-equity ratio of -170.06, a quick ratio of 1.52 and a current ratio of 0.83. The firm’s 50-day moving average price is GBX 920.11 and its two-hundred day moving average price is GBX 850.81.

Indivior Company Profile

Indivior PLC, together with its subsidiaries, engages in the development, manufacture, and sale of buprenorphine-based prescription drugs for the treatment of opioid dependence and co-occurring disorders in the United States, the United Kingdom, and internationally. The company develops medicines to treat substance use disorders, serious mental illnesses, and opioid overdose.